The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Inv Regulatory News (BRH)

Share Price Information for Braveheart Inv (BRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.25
Bid: 7.00
Ask: 7.50
Change: 0.50 (7.41%)
Spread: 0.50 (7.143%)
Open: 6.75
High: 7.25
Low: 6.75
Prev. Close: 6.75
BRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placing and subscription to raise £750,000

20 Sep 2022 07:00

RNS Number : 8406Z
Braveheart Investment Group plc
20 September 2022
 

Prior to publication, the information contained within this announcement was deemed by the Company to constitute inside information as stipulated under the UK Market Abuse Regulation. With the publication of this announcement, this information is now considered to be in the public domain.

 

20 September 2022

 

Braveheart Investment Group Plc

("Braveheart", the "Company" or the "Group")

 

Placing and subscription to raise £750,000

 

Braveheart Investment Group (AIM: BRH), announces that the Company has raised £750,000 (before expenses) by way of a placing of and subscription for new ordinary shares of 2p each ("Ordinary Shares") in the Company (together, the "Fundraise"), at an issue price of 10.25p pence per share (the "Issue Price").

 

The Company has issued 1,951,220 new Ordinary Shares ("Placing Shares") at the Issue Price pursuant to a placing, raising gross proceeds of £200,000.05 before expenses (the "Placing"). The Placing has been arranged by Peterhouse Capital Limited.

 

In addition, the Company has entered into a direct subscription with Trevor Brown, Chief Executive Officer, for a total of 5,365,853 new Ordinary Shares (the "Subscription Shares"), raising a total of £550,000 (the "Subscription"). Trevor Brown has undertaken to the Company that he will not dispose of any of the Subscription Shares for a period of one year from the date of admission to trading on the AIM market of the Subscription Shares, without the prior written consent of the Company and the Company's Nomad.

 

A total of 7,317,073 new Ordinary Shares (together the "Fundraise Shares") are to be issued at the Issue Price. The Fundraise has been conducted utilising the Company's existing share authorities granted at the Annual General Meeting of the Company held on 13 July 2022. The Fundraise is conditional, inter alia, on admission of the Fundraise Shares to trading on AIM ("Admission") becoming effective.

 

The Fundraise has been undertaken by the Company to enable it to be in sufficient funds to be able to support its current investee companies from a position of strength should the need arise for further funds and to be able to make opportunistic new investments.

 

Director's holding

 

Trevor Brown's total beneficial interest following this transaction will be 12,429,424 Ordinary Shares, representing approximately 19.51% of the voting rights in the Company's enlarged share capital following the issue of the Subscription Shares. The FCA notification, made in accordance with the requirements of the UK Market Abuse Regulation, is appended below.

 

Related Party Transaction

 

The subscriber for the Subscription Shares is Trevor Brown, who is the CEO and a Director of Braveheart and, therefore, the transaction is treated as a related party transaction under the AIM rules. The independent directors, being Qu Li, Susan Hagan and Vivian Hallam, consider, having consulted with Allenby Capital Limited, the Company's Nominated Adviser, that the terms of the Subscription and the issue of the Subscription Shares are fair and reasonable insofar as the shareholders of Braveheart are concerned.

 

Admission of the Fundraise Shares

 

Application has been made for the 7,317,073 Fundraise Shares to be admitted to trading on AIM ("Admission"), which is expected to take place on or around 26 September 2022. Once issued, the Fundraise Shares will rank pari passu in all respects with the existing Ordinary Shares of the Company.

 

Total Voting Rights

 

Following Admission, the Company's issued ordinary share capital will consist of 63,723,489 Ordinary Shares, all of which carry one voting right per share. The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of Ordinary Shares and voting rights in the Company will be 63,723,489. With effect from Admission, this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

For further information: 

Braveheart Investment Group plc

Tel: 01738 587555

Trevor Brown, Chief Executive Officer

Viv Hallam, Executive Director

Allenby Capital Limited (Nominated Adviser and Joint Broker)

Tel: 020 3328 5656

David Worlidge / James Reeve / George Payne

Peterhouse Capital Limited (Joint Broker)

Tel: 020 7469 0936

Heena Karani / Lucy Williams

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Trevor Brown

 

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Executive Officer

 

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Braveheart Investment Group plc

b)

 

LEI

 

2138006HQ3COMU626I61

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 2 pence each in Braveheart Investment Group plc

 

 

GB00B13XV322

b)

 

Nature of the transactions

 

issue of new Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

Price(s)

 

10.25p

 

 

Volume(s)

 

5,365,853

d)

 

Aggregated information

- Aggregated volume

- Price

- Principal amount

 

 

5,365,853

10.25p

£ 549,999.93

e)

 

Dates of the transaction

 

16 September 2022

f)

Place of transaction

Outside a trading venue

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOESFLFEAEESEFU
Date   Source Headline
2nd Sep 202211:20 amRNSHolding(s) in Company
1st Sep 20227:00 amRNSAcquisition of further interest in Aukett Swanke
31st Aug 20225:00 pmRNSTotal Voting Rights
4th Aug 20223:27 pmRNSHolding(s) in Company
3rd Aug 20225:05 pmRNSAcq of interest in Aukett Swanke plc - Replacement
3rd Aug 20224:10 pmRNSAcquisition of interest in Aukett Swanke Group plc
21st Jul 20227:03 amRNSOperational update on Paraytec
13th Jul 202211:41 amRNSResult of AGM
11th Jul 20227:00 amRNSDirector/PDMR Shareholding
27th Jun 20228:40 amRNSDirector/PDMR Shareholding
16th Jun 20227:00 amRNSFinal Results
9th May 20223:57 pmRNSReplacement - Cancellation and grant of options
9th May 20221:08 pmRNSCancellation and grant of options
29th Apr 20225:00 pmRNSTotal Voting Rights
6th Apr 20227:00 amRNSPlacing to raise £215,113
31st Mar 202212:17 pmRNSResult of General Meeting
28th Mar 20229:42 amRNSDirector/PDMR Shareholding
16th Mar 20227:00 amRNSNotice of GM and authority to issue shares
14th Mar 202211:23 amRNSDirector/PDMR Shareholding
9th Mar 20227:00 amRNSBlock admission six monthly return
8th Mar 20229:41 amRNSDirector/PDMR Shareholding
25th Feb 202211:06 amRNSSecond Price Monitoring Extn
25th Feb 202211:00 amRNSPrice Monitoring Extension
25th Feb 20227:00 amRNSOperational update
31st Jan 20227:00 amRNSHolding(s) in Company
28th Jan 20221:55 pmRNSHolding(s) in Company
21st Jan 20222:46 pmRNSOperational update on Paraytec
17th Jan 20223:23 pmRNSFurther re. Director/PDMR holding
17th Jan 20229:24 amRNSHolding(s) in Company
16th Dec 20217:00 amRNSNon Regulatory - PhaseFocus Update
8th Dec 20214:08 pmRNSDirector/PDMR Shareholding
8th Dec 20217:00 amRNSOperational update on Paraytec
26th Nov 20219:49 amRNSVideo from The University of Sheffield re Paraytec
15th Nov 20217:00 amRNSHalf-year Report
14th Oct 20211:46 pmRNSDirector/PDMR Shareholding
11th Oct 202111:02 amRNSHolding(s) in Company
11th Oct 20217:30 amRNSInvestment in Autins Group plc
30th Sep 20215:00 pmRNSTotal Voting Rights
30th Sep 20217:00 amRNSOperational update on various investments
28th Sep 202112:14 pmRNSHolding(s) in Company
9th Sep 20217:00 amRNSBlock admission six monthly return
31st Aug 20215:00 pmRNSTotal Voting Rights
13th Aug 202111:05 amRNSSecond Price Monitoring Extn
13th Aug 202111:00 amRNSPrice Monitoring Extension
13th Aug 20217:00 amRNSPlacing to raise £2.5 million
6th Aug 202111:05 amRNSSecond Price Monitoring Extn
6th Aug 202111:00 amRNSPrice Monitoring Extension
4th Aug 20212:40 pmRNSFurther update re Paraytec AD Scanner project
26th Jul 20215:49 pmRNSDirector/PDMR Shareholding
14th Jul 20212:37 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.